Fortrea Holdings Inc. Share Price

Equities

FTRE

US34965K1079

Biotechnology & Medical Research

Market Closed - Nasdaq 01:30:00 22/06/2024 am IST 5-day change 1st Jan Change
23.15 USD -3.26% Intraday chart for Fortrea Holdings Inc. -3.42% -33.67%
Sales 2024 * 2.8B 234B Sales 2025 * 2.93B 245B Capitalization 2.07B 173B
Net income 2024 * -123M -10.28B Net income 2025 * 42M 3.51B EV / Sales 2024 * 1.3 x
Net Debt 2024 * 1.57B 131B Net Debt 2025 * 1.44B 120B EV / Sales 2025 * 1.2 x
P/E ratio 2024 *
-22.2 x
P/E ratio 2025 *
38.3 x
Employees 16,000
Yield 2024 *
-
Yield 2025 *
-
Free-Float 99.87%
More Fundamentals * Assessed data
Dynamic Chart

Latest transcript on Fortrea Holdings Inc.

1 day-3.26%
1 week-3.42%
Current month-8.82%
1 month-12.24%
3 months-40.53%
6 months-33.57%
Current year-33.67%
More quotes
1 week
22.95
Extreme 22.95
25.07
1 month
22.95
Extreme 22.95
27.94
Current year
22.95
Extreme 22.95
41.02
1 year
22.95
Extreme 22.95
41.02
3 years
22.95
Extreme 22.95
41.02
5 years
22.95
Extreme 22.95
41.02
10 years
22.95
Extreme 22.95
41.02
More quotes
Date Price Change Volume
21/24/21 23.15 -3.26% 2,659,276
20/24/20 23.93 +2.53% 2,127,375
18/24/18 23.34 -2.99% 1,888,437
17/24/17 24.06 +0.38% 923,784
14/24/14 23.97 -2.96% 1,353,534

Delayed Quote Nasdaq, June 22, 2024 at 01:30 am IST

More quotes
Fortrea Holdings Inc. is a global contract research organization (CRO), which provides clinical development solutions to the life sciences industry. The Company is engaged in providing biopharmaceutical product and medical device development services to pharmaceutical, biotechnology and medical device customers. The Company offers customers flexible delivery models that include full service, functional service provider, and hybrid service structures. It provides phase I-IV clinical trial management, clinical pharmacology and consulting services. The Company manages its business through a single segment, Clinical Services, that provides services across the clinical pharmacology and clinical development spectrum. The Company has access to all key markets worldwide through a footprint of primary office locations in five countries (the United States, the United Kingdom, China, India and Singapore) with field operations in other jurisdictions worldwide.
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
11
Last Close Price
23.15 USD
Average target price
31.8 USD
Spread / Average Target
+37.37%
Consensus